Latest
27
Jun
The Biotech Deck Drinking Game
10 Slides You'll Always See
If you've been pitched by more than three biotech startups in
3 min read
26
Jun
The Pivot Paradox
Why constant reinvention is both vital—and a sign you may have no idea what you're doing
Once
3 min read
25
Jun
Global Pharma & Biotech M&A (Mar–Jun 2025): Deals, Drivers & Trends
The second quarter of 2025 saw a surge in mergers and acquisitions (M&A) within the pharmaceutical and biotechnology
35 min read
24
Jun
From Tricorders to Tribbles: When Sci-Fi Becomes a Patent Filing
It is a truth almost universally acknowledged—except, perhaps, in FDA review meetings—that no credible scientist gets funded anymore
5 min read
23
Jun
The shape of cures to come: AlphaFold’s structural revolution in drug discovery
The decades-long puzzle of protein folding
In the pantheon of scientific challenges, few have loomed as large or as stubborn
18 min read
22
Jun
No Cure Without Coverage: Digital Health’s Reimbursement Riddle
When a small Berlin startup launched an obesity therapy app a few years ago, investors hailed it as a potential
23 min read
21
Jun
Real-World Data (RWD): The Messy Yet Essential Future of Healthcare
Real-World Data (RWD) is the equivalent of field notes in anthropology: messy, unstructured, but full of valuable insights about how
3 min read
20
Jun
Of CEOs, Titles, and Other Startup Ailments: A Treatise on the Cult of Empty Authority
Startups are curious beasts. They move fast, break things, raise millions, and yet remain spectacularly unable to define who is
4 min read
19
Jun
The Biotech Platform Company Model: De-Risking Drug Development or VC Mirage?
Introduction: Platforms, Promise, and the VC Paradox
Biotechnology has always been a high-stakes endeavor, with the odds stacked against any
28 min read
18
Jun
The Dusty Tools of Management: Why We Still Cling to Outdated Frameworks
If you’ve been through business school, corporate training, or an executive retreat, chances are you’ve encountered the holy
4 min read